Xeris Biopharma Slashes Debt by $23 Million Through Private Exchange—Interest Savings Expected to Top $2 Million Annually
Market Chameleon (Fri, 12-Jun 10:30 AM)
Xeris Biopharma Delivers Strong Q1 Growth: Net Income Turns Positive, Recorlev Revenue Almost Doubles
Market Chameleon (Thu, 7-May 11:34 AM)
Xeris Biopharma Delivers 43% Revenue Growth and Swings to Profit as Recorlev Sales Nearly Double in Q1
Market Chameleon (Thu, 7-May 7:50 AM)
